China ADR Privatizations: The Challenges of Getting the Best Deal
The stellar performance of China’s stock markets over the past twelve months (Shanghai +121%, Shenzhen +161%, and Hong Kong +17%) has led to a...
603 Views
Opening of E-commerce Channel to Change China's Drug Market
Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...
602 Views
Introducing Long Term Leaders - Focussed Insights for your Core Holdings
We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category,  we have identified companies that...
497 Views
CSI 100 Index Earning Revision (Jan): CHINA VANKE, CMOC, TONGWEI, ZIJIN MINING, PING AN INSURANCE
We analyzed CSI 100's consensus for Jan 2026 and highlighted changes of EPS in CHINA VANKE, CMOC, TONGWEI, ZIJIN MINING, PING AN INSURANCE,...
296 Views
Pre-IPO IMPACT Therapeutics - Thoughts on the Pipeline, the Concerns and Valuation Outlook
​Senaparib shows promise in improving PFS but face commercialization challenge.Pipeline potential hinges on clinical success/approval...
357 Views